Healthnostics Provides Corporate Update

BETHESDA, Md.--(Business Wire)--
Healthnostics, Inc. (PINK SHEETS: HNSO), a medical and
biotechnology analytics company, is pleased to provide the following
update report regarding the Company's development and progress.

Trading in Healthnostics Stock

The recent decrease in our stock price over the past months has
occurred even though the value of our company has increased as
described in recent news releases by Healthnostics. Our opinion is the
Company's stock is undervalued based upon our assets and the
performance of our recent acquisition, GMD, Inc. Currently there are
1,956,538,155 shares outstanding, of which approximately 1,200,000,000
shares were issued in conjunction with the GMD transaction. The float
is currently approximately 440,000,000 shares. Long-term insiders hold
over 250,000,000 shares in the float.

The current market selling of our stock has not been undertaken by
the Company nor the insiders.

Strategy

The Company's strategy is to leverage, build or acquire compatible
healthcare technologies that will create valuable business offerings
from us in the healthcare and biotechnology information technology
market. To that end Healthnostics acquired a major interest in GMD,
Inc. a nationwide durable medical equipment provider specializing in
direct to consumer diabetic supplies. The company continues to
evaluate new acquisition and investment opportunities that are
compatible with our strategy.

GMD, Inc.

GMD's fiscal year ended June 30, 2008. Previously the Company
announced that GMD was on target for record revenues of nearly $10
million on a profitable basis. The actual results will be announced
after completion of the year-end closing.

MedBioWeb Corp.

MedBioWeb's medical and biotechnology professional portal
MedBioWorld.com continues to draw praise from its users and has an
increasing user base. New advertising and partner affiliate programs
are underway that have increased revenue.

Healthnostics is in the process of restructuring the MedBioWeb
Corp. spin-off and preparing a new registration statement. Previously,
Healthnostics announced that the Company had filed a registration
statement to spin-off MedBioWeb Corp., into a new, fully reporting
company.

Clinical Software Systems

MedGuardian, which addresses critical quality improvement issues
facing hospitals today, continues to be successfully marketed to
hospital associations, government and private sector hospitals
generating new and viable future sales opportunities. Healthnostics'
target market for MedGuardian is the 4,200 small to medium sized acute
care hospitals that constitute the majority of hospitals in the U.S.

For further information please visit Healthnostics
www.healthnostics.com, MedBioWorld www.medbioworld.com, MedNets
www.mednets.com, and FamilyMedicalNet www.familymedicalnet.com.

This press release may contain certain statements that are not
descriptions of historical information, but are forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Exchange Act of 1934. These
forward-looking statements refer to matters that involve risks and
uncertainties. Such statements reflect management's current views and
are based on certain assumptions. Actual results could differ
materially from the assumptions currently anticipated.

Healthnostics, Inc.
Michael Black, 410-295-3388
contact@healthnostics.com

Copyright Business Wire 2008